Wednesday September 20th 2017

A new way: Foundation lines up generic heart drug for multiple sclerosis trial

A generic high blood pressure drug could unlock a new treatment window for multiple sclerosis patients in a groundbreaking study championed by a Bay Area nonprofit. The Myelin Repair Foundation of Saratoga in the next few months will launch a Phase I safety trial of the drug, approved two decades ago to treat hypertension, said President and CEO Scott Johnson. But while the road to winning Food and Drug Administration approval as a low-cost MS treatment is as tricky as it would be for any other… (Source: bizjournals.com Health Care:Biotechnology headlines)

Originally posted here: 

A new way: Foundation lines up generic heart drug for multiple sclerosis trial

Leave a Comment

More from category

New man-made antioxidant could help improve success rates of cell-based therapies
New man-made antioxidant could help improve success rates of cell-based therapies

Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their [Read More]

Patient and Provider Organizations Oppose Graham-Cassidy Health Care Proposal
Patient and Provider Organizations Oppose Graham-Cassidy Health Care Proposal

/About-the-Society/News/Patient-and-Provider-Organizations-Oppose-Graham-C [Read More]

Researchers Discover Potential Driver of MS Disease Progression and Test Ways to Block It
Researchers Discover Potential Driver of MS Disease Progression and Test Ways to Block It

/About-the-Society/News/Researchers-Discover-Potential-Driver-of-MS-Diseas [Read More]

Scientists discover markers for progressive multiple sclerosis
Scientists discover markers for progressive multiple sclerosis

Scientists have uncovered two closely related cytokines -- molecules involved in cell communication and movement -- [Read More]

Study uncovers markers for severe form of multiple sclerosis
Study uncovers markers for severe form of multiple sclerosis

Scientists have uncovered two molecules involved in cell communication and movement that may explain why some people [Read More]